Evidence map›Paper›PMID 30416744›Full record

ArticleFuture science OA2018

Survival and glycemic control in patients with colorectal cancer and diabetes mellitus.

Nina J Karlin, Shailja B Amin, Heidi E Kosiorek, Matthew R Buras, Patricia M Verona, Curtiss B Cook

Open access · goldAbstract read
In one paragraph

Article in Future science OA, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nina J KarlinDivision of Hematology and Medical Oncology, Mayo Clinic Hospital, Phoenix, AZ 85054, USA.
Shailja B AminDivision of Hematology and Medical Oncology, Mayo Clinic Hospital, Phoenix, AZ 85054, USA.
Heidi E KosiorekBiostatistics, Mayo Clinic Hospital, Phoenix, AZ 85054, USA.
Matthew R BurasBiostatistics, Mayo Clinic Hospital, Phoenix, AZ 85054, USA.
Patricia M VeronaDepartment of Information Technology, Mayo Clinic Hospital, Phoenix, AZ 85054, USA.
Curtiss B CookDivision of Endocrinology, Mayo Clinic, Scottsdale, AZ 85259, USA.
Mayo Clinic Hospital · USMayo Clinic in Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe impact of diabetes mellitus (DM) on survival in patients with colorectal cancer and the impact of colorectal cancer on glycemic control were examined. MATERIALS &

methodsPatients with colorectal cancer with and without DM were matched 1:1 (2007-2015). Characteristics were compared between the two groups and survival assessed with the Kaplan-Meier method. Mixed models compared hemoglobin A

resultsIn both groups, glucose values decreased during the year following cancer diagnosis (p < 0.001). 5-year overall survival was 56% (95% CI: 42-68%) for DM patients versus 57% (95% CI: 43-69%) for non-DM patients (p = 0.62).

conclusionDM did not adversely impact survival of patients with colorectal cancer. Colorectal cancer did not affect glycemic control.

Indexed as

cancercolorectal cancerdiabetesendocrinologyglycemic controloutcomes research

Identifiers

PMID30416744
PMCPMC6222275
OpenAlexW2887164079

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.